Directory
>
Paul Barsanti
Paul Barsanti
Chief Technology Officer, Head of Drug Discovery | IDEAYA Biosciences
United States
Paul Barsanti
Summary
Paul Barsanti is a seasoned Chief Technology Officer and Head of Drug Discovery at IDEAYA Biosciences, bringing over 20 years of diverse experience in the pharmaceutical industry. He has a strong background in medicinal chemistry, biotechnology, and drug development, having led multidisciplinary teams in the discovery of new pharmaceutical agents. Paul has a proven track record of establishing effective chemistry departments within start-up environments, demonstrating his ability to lead change and innovate in complex situations. His leadership style is characterized by a strong commitment to mentorship, helping to cultivate the next generation of scientists. He has worked extensively in oncology and has held various leadership roles in notable organizations, including Novartis and Chiron. Paul is recognized for his strategic vision and ability to drive projects from conception through to successful execution. His academic credentials include a post-doctoral fellowship at the University of Illinois, underscoring his deep expertise in medicinal chemistry. Paul is passionate about advancing drug discovery processes and making a positive impact in the pharmaceutical field.
Paul Barsanti
Work Experience
Chief Technology Officer, Head of Drug Discovery at
IDEAYA Biosciences
March 2023 - Present
Senior Vice President, Head of Drug Discovery at
IDEAYA Biosciences
March 2021 - Present
VP, Head of Drug Discovery at
IDEAYA Biosciences
July 2019 - March 2021
Executive-in-Residence at 5AM Venture Partners, LLC at
5AM Ventures
June 2018 - June 2019
Director and Head of Chemistry at
Nurix Therapeutics
June 2014 - June 2018
Associate Director / Group Leader at
Novartis
September 2009 - May 2014
Research Investigator III and Project Leader at
Novartis
April 2006 - September 2009
Principle Scientist, Medicinal Chemistry at
Chiron Corporation
July 2004 - April 2006
Research Scientist II, Medicinal Chemistry at
Chiron Corporation
June 2001 - July 2004
Research Scientist I, Medicinal Chemistry at
Chiron Corporation
May 1999 - June 2001
Post Doctoral Research Fellow at
University of Illinois Community Credit Union
November 1996 - December 1998
Medicinal Chemist at
GSK
May 1991 - August 1992
Paul Barsanti
Education
January 1993 - January 1996
January 1989 - January 1993
Frequently Asked Questions about Paul Barsanti
What is Paul Barsanti email address?
Paul Barsanti's primary email address is *********@ideayabio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paul Barsanti work for?
Paul Barsanti is a Chief Technology Officer, Head of Drug Discovery at IDEAYA Biosciences, a company specializing in Commercial physical research.
Where Paul Barsanti graduated from?
Paul Barsanti holds a degree in from University of Bath.
How can I directly contact Paul Barsanti?
To contact Paul Barsanti directly, you can use the email address *********@ideayabio.com. Complete contact information is available upon registration with Muraena.
Who is Paul Barsanti?
Paul Barsanti is a seasoned Chief Technology Officer and Head of Drug Discovery at IDEAYA Biosciences, bringing over 20 years of diverse experience in the pharmaceutical industry. He has a strong background in medicinal chemistry, biotechnology, and drug development, having led multidisciplinary teams in the discovery of new pharmaceutical agents. Paul has a proven track record of establishing effective chemistry departments within start-up environments, demonstrating his ability to lead change and innovate in complex situations. His leadership style is characterized by a strong commitment to mentorship, helping to cultivate the next generation of scientists. He has worked extensively in oncology and has held various leadership roles in notable organizations, including Novartis and Chiron. Paul is recognized for his strategic vision and ability to drive projects from conception through to successful execution. His academic credentials include a post-doctoral fellowship at the University of Illinois, underscoring his deep expertise in medicinal chemistry. Paul is passionate about advancing drug discovery processes and making a positive impact in the pharmaceutical field.
Paul`s contact details
*********@ideayabio.com
*************@novartis.com
Colleagues
Senior Vice President, Head of Development Operations
Chief Scientific Officer
VP and Head of Medicinal Chemistry
Chief Medical Officer
Vice President, and Head, Pharmacology and Toxicology
Vice President Early Oncology Clinical Development
Vice President, Head of CMC
Vice President, Clinical Operations
Senior Vice President, Head of Finance and Investor Relations